An Evaluation of APTT Monitoring of Low-Dose Heparin Dosage in Hip Surgery

Summary

The activated partial thromboplastin time has been used to monitor the effects of low-dose subcutaneous heparin in two groups of patients undergoing hip surgery. The study was performed to determine the degree of anticoagulation required to protect these high-risk patients from post-operative deep vein thrombosis. The patients were randomised to receive a fixed regimen of subcutaneous calcium heparin (5,000 units eight-hourly) or a dose of calcium heparin monitored by maintaining the standardised APTT at 50 secs. In the adjusted group the APTT achieved the target figure in 46% of observations compared to 27% in the fixed group (p μ0.005). Nine patients showed positive ¹²⁵I-fibrinogen scans and in all, the APTT was below the target value the day before the scan became positive. In contrast, in six of the nine thrombotic patients heparin was detected by antifactor Xa clotting assay. The APTT, therefore, appears to give a better guide to the antithrombotic effect of heparin than the antifactor Xa clotting assay. These preliminary observations suggest that prolonging the standardised APTT method to just above 50 secs improves prophylaxis in high-risk cases. Furthermore, an increased dose of heparin is required than is provided during the conventional low-dose regime of 5,000 units tds. With regular control using the standardised APTT, increasing the dose to the target value does not increase postoperative haemorrhage.

Further studies with larger numbers of patients are required in order to show a significant reduction in the incidence of postoperative deep vein thrombosis in hip surgery patients receiving low-dose adjusted heparin.

Key words

APTT - Heparin - Hip surgery

• References

• 1 Thomson JeanM. Laboratory control of anticoagulant therapy. In: Blood Coagulation and Haemostasis: A Practical Guide. Ed. Thomson JM. 279-330 Churchill Livingstone; Edinburgh: 1980
• 2 Taberner DA, Norman C, Poller L, Burslem RW, Jones JB. The value of standardised partial thromboplastin time in detecting heparin during low-dose prophylaxis. Br J Haematol 1979; 43: 317-322
• 3 Taberner DA, Poller L, Burslem RW, Jones JB. Oral anticoagulants controlled by the British Comparative Thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J 1978; 1: 272-274
• 4 Denson KWE, Bonnar J. The measurement of heparin: A method based on the potentiation of antifactor Xa. Thrombos Diathes Haemorr 1973; 30: 471-481
• 5 Kakkar VV. Isotopie detection of deep vein thrombosis. In: Thromboembolism - Diagnosis and Treatment. Ed Kakkar VV, Jouhar AJ. 101-110 Curchill Livingstone; London: 1972
• 6 Sevitt S, Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fracture neck of femur. Lancet 1959; 2: 981-989